Ultragenyx Pharmaceutical Inc. RARE
- Crysvita — X-Linked Hypophosphatemia Approved
- Crysvita — Tumor-Induced Osteomalacia Approved
FGF23 (1 companies · 2 programs)
Companies with an active program directed at FGF23.
Companies with an active program directed at FGF23.